Disgust and behavioral avoidance in colorectal cancer screening and treatment: A systematic review and research agenda

Cancer Nursing

Volumn 36, Issue 2, 2013, Pages 122-130

  Reynolds, Lisa M ^a   Consedine, Nathan S ^a   Pizarro, David A ^b   Bissett, Ian P ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; CANCER PATIENT; CANCER SCREENING; CANCER THERAPY; CAREGIVER; COLORECTAL CANCER; DECISION MAKING; DISGUST; FEAR; HEALTH PRACTITIONER; HUMAN; PRIORITY JOURNAL; SHAME; SYSTEMATIC REVIEW; TREATMENT REFUSAL;

CAREGIVERS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEAR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NURSE-PATIENT RELATIONS; NURSING RESEARCH; ONCOLOGY NURSING; PHOBIC DISORDERS;

EID: 84874269470     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31826a4b1b     Document Type: Article

References (71)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 2010. http://globocan.iarc.fr. Accessed December 20, 2011.
2. Dollinger M, Rosenbaum EH, Tempero M, Mulvihull SJ. Everyone's Guide to Cancer Therapy: How Cancer is Diagnosed, Treated and Managed Day to Day. 4th ed. Kansas City, KS: Andrew McMeel Publishing; 2002.
3. Zabalegui A. Coping strategies and psychological distress in patients with advanced cancer. Oncol Nurs Forum. 1999;26(9):1511-1518.
4. Khankari K, Eder M, Osborn CY, et al. Improving colorectal cancer screening among the medically underserved: a pilot study within a federally qualified health center. J Gen Intern Med. 2007;22(10): 1410-1414.
5. Ristvedt SL, Trinkaus KM. Psychological factors related to delay in consultation for cancer symptoms. Psychooncology. 2005;14(5):339-350.
6. Manne S, Badr H, Zaider T, Nelson C, Kissane D. Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer. J Cancer Surviv. 2010; 4(1):74-85.
7. Ferrante JM, Chen P-H, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114-124.
8. Hohneker J, Shah-Mehta S, Brandt PS. Perspectives on adherence and persistence with oral medications for cancer treatment. J Oncol Pract. 2011;7(1):65-67.
9. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occultblood test. Lancet. 1996;348(9040):1467-1471.
10. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79(5/6):858-864.
11. Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24(30):4888-4894.
12. Kondryn HJ, Edmondson CL, Hill J, Eden TOB. Treatment nonadherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100-108.
13. Consedine NS, Ladwig I, Reddig MK, Broadbent EA. The many faeces of colorectal cancer screening embarrassment: preliminary psychometric development and links to screening outcome. Br J Health Psychol. 2011; 16(3):559-579.
14. Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev. 2004;13(4):501-510.
15. Consedine NS, Moscowitz JT. The role of discrete emotions in health outcomes: a critical review. Appl Prev Psychol. 2007;12(2):59-75.
16. Curtis V, Aunger R, Rabie T. Evidence that disgust evolved to protect from risk of disease. Proc R Soc Lond B Biol Sci. 2004;271(suppl 4): S131-S133.
17. Davey GCL, Bond N. Using controlled comparisons in disgust psychopathology research: the case of disgust, hypochondriasis and health anxiety. J Behav Ther Exp Psychiatry. 2006;37(1):4-15.
18. Angyal A. Disgust and related aversions. J Abnorm Soc Psychol. 1941; 36(3):393-412.
19. Elfenbein HA, Ambady N. On the universality and cultural specificity of emotion recognition: a meta-analysis. Psychol Bull. 2002;128(2): 203-235.
20. Rozin P, Haidt J, McCauley CR. Disgust. In: Lewis M, Haviland-Jones J, eds. Handbook of Emotions. 2nd ed. New York: Guilford; 2000:637-653.
21. Berle D, Phillips ES. Disgust and obsessive-compulsive disorder: an update. Psychiatry. 2006;69(3):228-238.
22. Olatunji BO, Sawchuk CN. Disgust: characteristic features, social manifestations, and clinical implications. J Soc Clin Psychol. 2005;24(7): 932-962.
23. Nemeroff CB, Rozin P. The contagion concept in adult thinking in the United States: transmission of germs and of interpersonal influence. Ethos. 1994;22(2):158-186.
24. Neuberg SL, Kenrick DT, Schaller M. Human threat management systems: self-protection and disease avoidance. Neurosci Biobehav Rev. 2011;35(4):1042-1051.
25. Curtis V, de Barra M, Aunger R. Disgust as an adaptive system for disease avoidance behaviour. Philos Trans R Soc B. 2011;366(1563):389-401.
26. Raman L, Gelman SA. Do children endorse psychosocial factors in the transmission of illness and disgust? Dev Psychol. 2008;44(3):801-813.
27. Navarrete CD, Fessler DMT. Disease avoidance and ethnocentrism: the effects of disease vulnerability and disgust sensitivity on intergroup attitudes. Evol Hum Behav. 2006;27(4):270-282.
28. Park JH, Faulkner J, Schaller M. Evolved disease-avoidance processes and contemporary anti-social behavior: prejudicial attitudes and avoidance of people with physical disabilities. J Nonverbal Behav. 2003;27(2):65.
29. Schnall S, Haidt J, Clore GL, Jordan AH. Disgust as embodied moral judgment. Pers Soc Psychol B. 2008;34(8):1096.
30. Inbar Y, Pizarro DA, Knobe J, Bloom P. Disgust sensitivity predicts intuitive disapproval of gays. Emotion. 2009;9(3):435-439.
31. Rozin P, Haidt J, McCauley CR, Dunlop L, Ashmore M. Individual differences in disgust sensitivity: comparisons and evaluations of paperand- pencil versus behavioral measures. J Res Pers. 1999;33(3):330-351.
32. Sussner KM, Thompson HS, Jandorf L, et al. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent. Psychooncology. 2009;18(9):945-955.
33. Chapman GB, Coups EJ. Emotions and preventive behavior: worry, regret, and influenza vaccination. Health Psychol. 2006;25(1):82-90.
34. Von Wagner C, Knight K, Halligan S, et al. Patient experiences of colonoscopy, barium enema and CT colonography: a qualitative study. Br J Radiol. 2009;82(973):13-19.
35. Brouse CH, Basch CE, Wolf RL, Shmukler C. Barriers to colorectal cancer screening: an educational diagnosis. J Cancer Educ. 2004;19(3): 170-173.
36. Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66(12):2425-2435.
37. Deutekom M, Van Rossum LGM, Van Rijn AF, et al. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective. Scand J Gastroenterol. 2010;45(11): 1345-1349.
38. Friedemann-Sanchez G, Griffin JM, Partin MR. Gender differences in colorectal cancer screening barriers and information needs. Health Expect. 2007;10(2):148-160.
39. Goldenberg JL, Arndt J, Hart J, Routledge C. Uncovering an existential barrier to breast self-exam behavior. J Exp Soc Psychol. 2008;44(2): 260-274.
40. Hillyer GC. Factors Related to Colorectal Cancer Screening With the Fecal Immunochemical Test among Uninsured Hispanic Women in Upper Manhattan [dissertation]. New York: Teachers College, Columbia University; 2011.
41. O'Sullivan I, Orbell S. Self-sampling in screening to reduce mortality from colorectal cancer: a qualitative exploration of the decision to complete a faecal occult blood test (FOBT). J Med Screen. 2004;11(1):16-22.
42. Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med. 2001;32(6):502-513.
43. Worthley DL, Cole SR, Esterman A, et al. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Intern Med J. 2006;36(9):607-610.
44. Akute OO. Colorectal carcinoma in Ibadan, Nigeria: a 20-year surveyV 1971 to 1990. Hepatogastroenterology. 2000;47(33):709-713
45. Carey CL, Harris LM. The origins of blood-injection fear/phobia in cancer patients undergoing intravenous chemotherapy. Behav Change. 2005;22(4):212-219.
46. Hardy D. When We Dare Not Speak Its Name: Anal Taboo, Anal Health, and Affect Theory [dissertation]. Pennsylvania, PA: Widener University; 2010.
47. Harris LM, Jones MK, Carey CL. Characteristics of blood-injectioninjury fears in people receiving intravenous chemotherapy. Curr Psychol. 2009;28(2):124-132.
48. Gullo L, Tomassetti P, Migliori M, Casadei R, Marrano D. Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis? Pancreas. 2001;22(2):210-213.
49. Rosman S. Cancer and stigma: experience of patients with chemotherapy- induced alopecia. Patient Educ Couns. 2004;52(3):333-339.
50. Haidt J, McCauley C, Rozin P. Individual differences in sensitivity to disgust: a scale sampling seven domains of disgust elicitors. Pers Indiv Differ. 1994;16:701-713.
51. Consedine NS, Adjei BA, Ramirez PM, McKiernan J. An object lesson: differences in source determine the relations that trait anxiety, prostate cancer worry, and fear of screening hold with prostate screening frequency. Cancer Epidemiol Biomarkers. 2008;17(7):1631-1639.
52. van Overveld M, de Jong PJ, Peters ML, Schouten E. The Disgust Scale-R: a valid and reliable index to investigate separate disgust domains? Pers Indiv Differ. 2011;51(3):325-330.
53. Olatunji BO, Williams NL, Tolin DF, et al. The Disgust Scale: item analysis, factor structure, and suggestions for refinement. Psychol Assess. 2007;19(3):281-297.
54. O'Malley AS, Kerner J, Johnson AE, Mandelblatt JS. Acculturation and breast cancer screening among Hispanic women in New York city. Am J Public Health. 1999;89(2):219-227.
55. Lyman GH, Dale DC, Crawford J. Incidence and predictors of low doseintensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol. 2003;21(24):4524-4531.
56. Tsunoda A, Yasuda N, Nakao K, et al. Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11). Int J Clin Oncol. 2010;15(3):280-286.
57. Fessler DMT, Eng SJ, Navarrete CD. Elevated disgust sensitivity in the first trimester of pregnancy: evidence supporting prophylaxis the compensatory hypothesis. Evol Hum Behav. 2005;26(4):344-351.
58. Biron P, Fuhrmann C, Escande MC, et al. Standards, options and recommendations (SOR) for the management of neutropenic cancer patients (excluding prolonged neutropenia). Bull. Cancer (Paris). 1998; 85(8):695-711.
59. Rubenstein EB, Rolston K. Outpatient management of febrile episodes in neutropenic cancer-patients. Support Care Cancer. 1994;2(6):369-373.
60. Smith DM, Loewenstein G, Rozin P, Sherriff RL, Ubel PA. Sensitivity to disgust, stigma, and adjustment to life with a colostomy. J Res Pers. 2007;41(4):787-803.
61. Holmes S. Food avoidance in patients undergoing cancer chemotherapy. Support Care Cancer. 1993;1(6):326-330.
62. Cantora R, Lopez M, Aguado L, Rana S, Parker LA. Extinction of a saccharin-lithium association: assessment by consumption and taste reactivity. Learn Behav. 2006;34(1):37-43.
63. McMullen CK, Hornbrook MC, Grant M, et al. The greatest challenges reported by long-term colorectal cancer survivors with stomas. J Support Oncol. 2008;6(4):175-182.
64. Faulkner J, Schaller M, Park JH, Duncan LA. Evolved disease-avoidance mechanisms and contemporary xenophobic attitudes. Group Proc Intergroup Relat. 2004;7(4):333-353.
65. MacDonald LD, Anderson HR. Stigma in patients with rectal cancer: a community study. J Epidemiol Community Health. 1984;38(4):284.
66. Olatunji BO, Haidt J, McKay D, David B. Core, animal reminder, and contamination disgust: three kinds of disgust with distinct personality, behavioral, physiological, and clinical correlates. J Res Pers. 2008;42(5): 1243-1259.
67. Sawchuk CN, Lohr JM, Westendorf DH, Meunier SA, Tolin DF. Emotional responding to fearful and disgusting stimuli in specific phobics. Behav Res Ther. 2002;40(9):1031-1046.
68. Overton PG, Markland FE, Taggart HS, Bagshaw GL, Simpson J. Selfdisgust mediates the relationship between dysfunctional cognitions and depressive symptomatology. Emotion. 2008;8(3):379-385.
69. de Jong PJ, van Lankveld J, Elgersma HJ, Borg C. Disgust and sexual problems-theoretical conceptualization and case illustrations. Int J Cogn Ther. 2010;3(1):23-39.
70. Franklin ME, Foa EB. Treatment of obsessive compulsive disorder. Annu Rev Clin Psycho. 2011;7:229-243.
71. Baer RA,Walsh E, Lykins ELB. Assessment of mindfulness. In: Didonna F, ed. Clinical Handbook of Mindfulness. New York: Springer; 2009:153-168.